Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.54 | 14.18 |
| PEG Ratio (TTM) | 0.76 | -0.44 |
| P/S Ratio (TTM) | 0.42 | 1.83 |
| P/B Ratio (TTM) | 15.87 | 2.13 |
| P/FCF Ratio (TTM) | 4.31 | 9.98 |
| Price to 5YR AVG Earnings Ratio | -1.70 | 21.41 |
| Price to 5YR AVG FCF Ratio | 2.72 | -32.01 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.28% | 2.68% |
| ROE (TTM) | -493.93% | 8.40% |
| Net Profit Margin (TTM) | -16.06% | -1.79% |
| ROIC 5YR AVG | 3.09% | 7.67% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -680.68% | 47.80% | -123.46% |
| Revenue | -2.99% | -5.64% | -8.97% |
| Net Income | -685.71% | 45.87% | -120.76% |
| Cash Flow | 68.39% | -2.57% | -17.85% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.20 | 0.82 |
| Quick Ratio (TTM) | 1.16 | 0.76 |
| D/E Ratio (TTM) | 55.03 | 1.42 |
| Interest Coverage (TTM) | 0.35 | 5.36 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | N/A | 1.06 |
| LTL to 5YR AVG FCF | 9.70 | -9.38 |
| Shares Outstanding Growth 5YR AVG | -1.53% | 31.62% |